Imo, the report is still tends towards the horrific, cash receipts for same period last year was $6.5 million compared to $4.3 million....
And I don't even want to delve too deeply into what the margins are possibly at now.
Still, there's something to build off. The thing that's closest is probably Alexiflam opportunity in Europe now that they're REACH compliant.
Imo, the report is still tends towards the horrific, cash...
Add AJX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.74M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 462637 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 420051 | 3 |
View Market Depth
| Last trade - 10.16am 05/07/2024 (20 minute delay) ? |
| AJX (ASX) Chart |
Day chart unavailable